Diagnosis of SARS-CoV-2 infection from breath - a proof-of-concept study
- PMID: 36345367
- PMCID: PMC9630292
- DOI: 10.1016/j.ijregi.2022.10.007
Diagnosis of SARS-CoV-2 infection from breath - a proof-of-concept study
Abstract
Bioaerosol capture and analysis is emerging as a non-invasive diagnostic method for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this proof-of-concept study conducted in Lesotho, we evaluated the novel and simple AL2 bioaerosol detection device in comparison to conventional nasopharyngeal sampling methods. We demonstrated for the first time that SARS-CoV-2 can be detected using the AL2 bioaerosol capture device. However, studies with a larger sample size are needed to further evaluate this bioaerosol capture device for the detection of SARS-CoV-2.
Keywords: COVID-19; Lesotho; SARS-CoV-2; bioaerosol capture device.
© 2022 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. AL2 Impact and 3M Company provided the bioaerosol capture devices and gave technical advice, but were not involved in data analysis.
References
LinkOut - more resources
Full Text Sources
Miscellaneous
